Aldosterone modifies hemostasis via upregulation of the protein-C receptor in human vascular endothelium

Biochemical and Biophysical Research Communications

Volumn 373, Issue 2, 2008, Pages 192-196

  Ducros, Elodie ^a   Berthaut, Alexandre ^a   Mirshahi, Shah Sultan ^b   Faussat, Anne M ^a   Soria, Jeannette ^a   Agarwal, Manjul K ^a   Mirshahi, Massoud ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b Stago R and D   (France)

Author keywords

Aldactone; Aldosterone; EPCR; Eplerenone; Protein C

Indexed keywords

ACTIVATED PROTEIN C; ALDOSTERONE; ENDOTHELIAL PROTEIN C RECEPTOR; EPLERENONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE;

ARTICLE; BLOOD CLOTTING TIME; BONE MARROW CELL; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; DOT HYBRIDIZATION; DOWN REGULATION; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; HEMOSTASIS; HORMONE ACTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; UPREGULATION;

ALDOSTERONE; ANTIGENS, CD; BLOOD COAGULATION; CELL MEMBRANE; CELLS, CULTURED; CYTOPLASM; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMOSTASIS; HUMANS; PARTIAL THROMBOPLASTIN TIME; RECEPTORS, CELL SURFACE; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER; UP-REGULATION;

EID: 46049110086     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.185     Document Type: Article

References (34)

1. Neves M.F., Amiri F., Virdis A., Diep Q.N., and Schiffrin E.L. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Can. J. Physiol. Pharmacol. 83 (2005) 999-1006
2. Brown N.J. Aldosterone and end-organ damage. Curr. Opin. Nephrol. Hypertens. 14 (2005) 235-241
3. Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J. Hypertens. Suppl. 23 (2005) S9-S17
4. Neal B., MacMahon S., and Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 9246 (2000) 1955-1964
5. Connell J.M., and Davies E. The new biology of aldosterone. J. Endocrinol. 186 (2005) 1-20
6. Agarwal M.K. Perspectives in receptor mediated mineralocorticoid hormone action. Pharmacol. Rev. 46 (1994) 67-87
7. Agarwal M.K., and Mirshahi M. General overview of mineralocorticoid hormone action. Pharmacol. Ther. 84 (1999) 273-326
8. Golestaneh N., Klein C., Valamanesh F., Suarez G., Agarwal M.K., and Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem. Biophys. Res. Commun. 280 (2001) 1300-1306
9. Chen W., Valamanesh F., Mirshahi T., Soria J., Tang R., Agarwal M.K., and Mirshahi M. Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells. Vascul. Pharmacol. 40 (2004) 269-277
10. Lehr J.E., and Pienta K.J. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J. Natl. Cancer Inst. 90 (1998) 118-123
11. Ducros E., Berthaut A., Mirshahi P., Lemarchand S., Soria J., Legeais J.M., and Mirshahi M. Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts. Curr. Eye Res. 32 (2007) 481-490
12. Taylor F.B., Peer G.T., Lockhart M.S., Ferrell G., and Esmon C.T. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 97 (2001) 1685-1688
13. Vu T.K., Hung D.T., Wheaton V.I., and Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64 (1991) 1057-1068
14. Bankl H.C., and Valenta P. Mast cells, thrombosis, and fibrinolysis: the emerging concept. Thromb. Res. 105 (2002) 359-365
15. Grabarek J., Groopman J.E., Lyles Y.R., Jiang S., Bennett L., Zsebo K., and Avraham H. Human kit ligand (SCF) modulates platelet activation in vitro. J. Biol. Chem. 269 (1994) 21718-21724
16. Arisato T., Hashiguchi T., Sarker K.P., Arimura K., Asano M., Matsuo K., Osame M., and Maruyama I. Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. J. Thromb. Haemost. 12 (2003) 2589-2593
17. Prager G.W., Breuss J.M., Steurer S., Mihaly J., and Binder B.R. Blood, vascular endothelial growth factor induces rapid prourokinase activation on the surface of endothelial cells. Blood 103 (2004) 955-962
18. Hiller O., Lichte A., Oberpichler A., Kocourek A., and Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J. Biol. Chem. 275 (2000) 33008-33013
19. Krikun G., Schatz F., Mackman N., Guller S., Demopoulos R., and Lockwood C.J. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3. Mol. Endocrinol. 14 (2000) 393-400
20. Rappold I., Ziegler B.L., Köhler I., Marchetto S., Rosnet O., Birnbaum D., Simmons P.J., Zannettino A.C., Hill B., Neu S., Knapp W., Alitalo R., Alitalo K., Ullrich A., Kanz L., and Bühring H.J. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 90 (1997) 111-125
21. Prechtel A.T., and Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch. Dermatol. Res. 299 (2007) 59-69
22. Wagner N., Löhler J., Kunkel E.J., Ley K., Leung E., Krissansen G., Rajewsky K., and Müller W. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382 (1996) 366-370
23. Ferguson J.E., Wu Y., Smith K., Charles P., Powers K., Wang H., and Patterson C C. ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism. Mol. Cell Biol. 27 (2007) 6407-6419
24. Saposnik B., Reny J.L., Gaussem P., Emmerich J., Aiach M., and Gandrille S. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 103 (2004) 1311-1318
25. Fukudome K., and Esmon C.T. Identification, cloning, and regulation of a novel endothelial cell protein C-activated protein C receptor. J. Biol. Chem. 269 (1994) 26486-26491
26. Taylor F.B., Stearns-Kurosawa D.J., Kurosawa S., Ferrell G., Chang A.C., Laszik Z., Kosanke S., Peer G., and Esmon C.T. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95 (2000) 1680-1686
27. Domotor E., Benzakour O., Griffin J.H., Yule D., Fukudome K., and Zlokovic B.V. Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood 101 (2003) 4797-4801
28. Xue M., Thompson P., Kelso I., and Jackson C. Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes. Exp. Cell Res. 299 (2004) 119-127
29. Riewald M., Petrovan R.J., Donner A., Mueller B.M., and Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 5574 (2002) 1880-1882
30. Mosnier L.O., Zlokovic B.V., and Griffin J.H. The cytoprotective protein C pathway. Blood 109 (2007) 3161-3172
31. Esmon C.T. Inflammation and the activated protein C anticoagulant pathway. Semin. Thromb. Hemost. 32 (2006) 49-60
32. Joyce D.E., Gelbert L., Ciaccia A., DeHoff B., and Grinnell B.W. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J. Biol. Chem. 276 (2001) 11199-11203
33. Feistritzer C., Lenta R., and Riewald M. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling. J. Thromb. Haemost. 12 (2005) 2798-2805
34. Takeda Y., Miyamori I., Yoneda T., Hatakeyama H., Inaba S., Furukawa K., Mabuchi H., and Takeda R. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. J. Clin. Endocrinol. Metab. 81 (1996) 2797-2800